Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Immunological Predictive Markers of Response to Idecabtagene Vicleucel Therapy in Multiple Myeloma : A Real-World Experience from St Louis Hospital (France)

Benoit Ferment, Amani Ouedrani, Romain Stammler, William Dartois, Stephanie Harel, Bruno Royer, Nathalie Forgeard, Tristan Vaugeois, Alexis Talbot, Jean-Christophe Bories, Bertrand Arnulf, Sophie Caillat-Zucman

Blood (2024) 144 (Supplement 1): 4760.

https://doi.org/10.1182/blood-2024-203460

Published: 2024

Journal Articles

Characteristics and Outcome Determinants in Children, Adolescents and Young Adults Who Failed Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 1433.

https://doi.org/10.1182/blood-2024-209895

Published: 2024

Journal Articles

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Blood (2023) 142 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2023-175045

Published: 2023

Journal Articles

Changes in the Immunogenetic Landscape with the Age of Disease Onset in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria: An Analysis of a Cohort of Adult and Pediatric Patients from the French National Reference Center for Aplastic Anemia

Vincent Allain, Juliette Villemonteix, Thierry Leblanc, Florian Chevillon, Catherine Fortier, Mony Fahd, Jean-Hugues Dalle, Gerard Socié, Regis Peffault De Latour, Sophie Caillat-Zucman, Flore Sicre De Fontbrune

Blood (2023) 142 (Supplement 1): 1339.

https://doi.org/10.1182/blood-2023-185528

Published: 2023

Journal Articles

IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria

Blood (2023) 141 (25): 3122–3125.

https://doi.org/10.1182/blood.2023020108

Published: 2023

Includes: Supplemental data

Journal Articles

Molecular International Prognostic Scoring System (IPSS-M) in Myelodysplastic Syndromes Arising from Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Blood (2022) 140 (Supplement 1): 5788–5789.

https://doi.org/10.1182/blood-2022-160458

Published: 2022

Journal Articles

Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse

Viviane Gournay, Nicolas Vallet, Vivien Peux, Kristi Vera, Jennifer Bordenave, Marion Lambert, Aurélien Corneau, David Michonneau, Régis Peffault de Latour, Sophie Caillat-Zucman, Gérard Socié, Mathieu F. Chevalier

Blood (2022) 140 (11): 1305–1321.

https://doi.org/10.1182/blood.2022015522

Published: 2022

Includes: Supplemental data

Journal Articles

Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation for Adolescents and Adults with Sickle Cell Disease

Loïc Vasseur, Florence Morin, Corinne Pondarré, Florian Chevillon, Aude-Marie Fourmont, Regis Peffault De Latour, Nicolas Boissel, Hélène Moins-Teisserenc, Sophie Caillat-Zucman, Nathalie Dhedin

Blood (2021) 138 (Supplement 1): 3907.

https://doi.org/10.1182/blood-2021-147133

Published: 2021

Journal Articles

Immunogenetic, Molecular and Clinical Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Blood (2021) 138 (Supplement 1): 602.

https://doi.org/10.1182/blood-2021-147556

Published: 2021

Journal Articles

Lenalidomide Exposure at Time of CAR T-Cells Expansion Enhances Response of Refractory/Relapsed Aggressive Large B-Cell Lymphomas

Jean Lemoine, Florence Morin, Roberta Di Blasi, Laetitia Vercellino, Alexis Cuffel, Naoufal Benlachgar, Jerome Larghero, Isabelle Madelaine, Julien Calvani, Veronique Meignin, Sophie Caillat-Zucman, Sylvie Chevret, Catherine Thieblemont

Blood (2021) 138 (Supplement 1): 1433.

https://doi.org/10.1182/blood-2021-151109

Published: 2021

Journal Articles

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Blood (2021) 138 (Supplement 1): 743.

https://doi.org/10.1182/blood-2021-148626

Published: 2021

Journal Articles

Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion

Catherine Thieblemont, MD PhD, Sylvie Chevret, MD PhD, Vincent Allain, Roberta Di Blasi, Florence Morin, Laetitia Vercellino, Sandrine Roulland, PhD, Karin Tarte, PhDPharmD, Veronique Meignin, Sophie Caillat-Zucman, MD PhD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-136279

Published: 2020

Journal Articles

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Blood (2019) 134 (Supplement_1): 3876.

https://doi.org/10.1182/blood-2019-131123

Published: 2019

Journal Articles

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Marie-Thérèse Rubio, Lucia Moreira-Teixeira, Emmanuel Bachy, Marie Bouillié, Pierre Milpied, Tereza Coman, Felipe Suarez, Ambroise Marcais, David Sibon, Agnès Buzyn, Sophie Caillat-Zucman, Marina Cavazzana-Calvo, Bruno Varet, Michel Dy, Olivier Hermine, Maria Leite-de-Moraes

Blood (2012) 120 (10): 2144–2154.

https://doi.org/10.1182/blood-2012-01-404673

Published: 2012

Includes: Supplemental data

Journal Articles

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Marie T Rubio, Lucia Teixeira, Pierre Milpied, Emmanuel Bachy, Felipe Suarez, David Ghez, Richard Delarue, Agnès Buzyn, Sophie Caillat-Zucman, Bruno Varet, Olivier Hermine, Maria Leite de Moraes

Blood (2009) 114 (22): 346.

https://doi.org/10.1182/blood.V114.22.346.346

Published: 2009

Journal Articles

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype

Marina Cavazzana-Calvo, Frédérique Carlier, Françoise Le Deist, Estelle Morillon, Pierre Taupin, David Gautier, Isabelle Radford-Weiss, Sophie Caillat-Zucman, Bénédicte Neven, Stephane Blanche, Rémi Cheynier, Alain Fischer, Salima Hacein-Bey-Abina

Blood (2007) 109 (10): 4575–4581.

https://doi.org/10.1182/blood-2006-07-029090

Published: 2007

Journal Articles

Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma

Marion Lambert, Monique Gannagé, Alexandre Karras, Michal Abel, Christophe Legendre, Delphine Kerob, Felix Agbalika, Pierre-Marie Girard, Celeste Lebbe, Sophie Caillat-Zucman

Blood (2006) 108 (12): 3871–3880.

https://doi.org/10.1182/blood-2006-03-014225

Published: 2006

Includes: Supplemental data

NARROW

Immunological Predictive Markers of Response to Idecabtagene Vicleucel Therapy in Multiple Myeloma : A Real-World Experience from St Louis Hospital (France)

Characteristics and Outcome Determinants in Children, Adolescents and Young Adults Who Failed Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia

Low Disease Burden Pre-CAR-T Cell Therapy for Children and AYA with B-ALL Is Associated with an Impaired Outcome When Obtained through Intensification of the Bridging Therapy

Changes in the Immunogenetic Landscape with the Age of Disease Onset in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria: An Analysis of a Cohort of Adult and Pediatric Patients from the French National Reference Center for Aplastic Anemia

IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria

Molecular International Prognostic Scoring System (IPSS-M) in Myelodysplastic Syndromes Arising from Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse

Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation for Adolescents and Adults with Sickle Cell Disease

Immunogenetic, Molecular and Clinical Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Lenalidomide Exposure at Time of CAR T-Cells Expansion Enhances Response of Refractory/Relapsed Aggressive Large B-Cell Lymphomas

Kte-X19 in Relapsed or Refractory Mantle-Cell Lymphoma, a "Real-Life" Study from the Descar-T Registry and Lysa Group

Lenalidomide Enhance CAR T-Cells Response in Patients with Refractory/Relapsed Large B Cell Lymphoma Experiencing Progression after Infusion

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Impact of Donor-Derived Invariant Natural Killer T (iNKT) Cell Reconstitution After Allogeneic Haematopoietic Stem Cell Transplantation.

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype

Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only